Radioiodine treatment of non-toxic multinodular goitre: Effects of combination with lithium

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 9, 2005, Pages 1081-1088

  Vannucchi, Guia ^a   Chiti, Arturo ^b   Mannavola, Deborah ^a   Dazzi, Davide ^a   Rodari, Marcello ^b   Tadayyon, Sara ^b   Beck Peccoz, Paolo ^a   Fugazzola, Laura ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Anti thyroid antibodies; Lithium; Multinodular goitre; Radioiodine therapy; Thyroid volume

Indexed keywords

IODINE 131; LITHIUM; THYROID ANTIBODY; THYROTROPIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYST; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DYSPHAGIA; ECHOGRAPHY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; NAUSEA; NECK PAIN; NODULAR GOITER; ORGAN SIZE; PATIENT; RANDOMIZED CONTROLLED TRIAL; RECORDING; SINGLE BLIND PROCEDURE; THYROID GLAND; THYROID NODULE; THYROTOXICOSIS; TISSUE; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; LITHIUM; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 25144476200     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-1818-8     Document Type: Article

References (25)

1. Berghout A, Wiersinga WM, Drexhage HA, Smiths NJ, Touber JL. Comparison of placebo with L-thyroxine alone or with car bimazole for treatment of sporadic non-toxic goiter. Lancet 1990;336:193-7.
2. Wiersinga WM. Determinants of outcome in sporadic nontoxic goiter. Thyroidology 1992;4:41-3.
3. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-52.
4. Faber J, Galloe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol 1994;130:350-6.
5. Kay TWH, D'Endem MC, Andrews JT, Martin FIR. Treatment of non-toxic multinodular goiter with radioactive iodine. Am J Med 1988;84:19-22.
6. Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goiter. Br Med J 1988;297:661-2.
7. Verelst J, Bonnyns M, Glinoer D. Radioiodine therapy in voluminous multinodular non-toxic goiter. Acta Endocrinol (Copenh) 1990;122:417-21.
8. Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soe-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goiter. Br Med J 1993;307:828-32.
9. Huysman DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994;121:757-62.
10. Le Moli R, Wesche MFT, Tiel-van Buul MMC, Wiersinga WM. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goiter. Clin Endocrinol 1999;50:783-9.
11. Wesche MFT, Tiel-v Buul MMC, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic non-toxic goiter. J Clin Endocrinol Metab 2001;86:998-1005.
12. 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 1997;82:2926-30.
13. de Klerk JM, van Isselt JW, van Dijk A, Hakman ME, Pameijer FA, Koppeschaar HP, et al. Iodine-131 therapy in sporadic non-toxic goiter. J Nucl Med 1997;38:372-6.
14. Nieuwlaat WA, Huysmans DA, van den Bosch HC, Sweep CGF, Ross HA, Corstens FH, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003;88:3121-9.
15. Silva MN, Rubio IG, Romao R, Gebrin EM, Buchpiguel C, Tomimori E, et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters. Clin Endocrinol 2004;60:300-8.
16. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. J Clin Endocrinol Metab 2001;86:5330-6.
17. Wolff J, Berens SC, Jones AB. Inhibition of thyrotropin-stimulated adenyl cyclase activity of beef thyroid membranes by low concentration of lithium ion. Biochem Biophys Res Commun 1970;39:77-82.
18. Bogazzi F, Bartalena L, Campomori A, Brogioni S, Traino C, De Martino F, et al. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease. J Clin Endocrinol Metab 2002;87:4490-5.
19. Pons F, Carrio I, Estorch M, Ginjaume M, Pons J, Milian R. Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma. Clin Nucl Med 1987;12:644-7.
20. 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metab 1999;84:912-6.
21. Rago T, Chiovato L, Aghini-Lombardi F, Grasso L, Pinchera A, Vitti P. Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up. J Endocrinol Invest 2001;24:770-6.
22. 131I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 1995;132:86-7.
23. 131I treatment of nodular non-toxic goiter. Eur J Endocrinol 1996;134:15-20.
24. Huysman D, Hermus A, Edelbroek M, Barentsz J, Corstens F, Kloppenborg P. Radioiodine for non-toxic multinodular goiter. Thyroid 1997;7:235-9.
25. Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. 3rd ed. USA: W.H. Freeman and Company; 1995. p. 151.